Literature DB >> 15976386

Calcium dependence of proteinase-activated receptor 2 and cholecystokinin-mediated amylase secretion from pancreatic acini.

Anupriya Sharma1, Xiaohong Tao, Arun Gopal, Brooke Ligon, Michael L Steer, George Perides.   

Abstract

Pancreatic acini secrete digestive enzymes in response to a variety of secretagogues including CCK and agonists acting via proteinase-activated receptor-2 (PAR2). We employed the CCK analog caerulein and the PAR2-activating peptide SLIGRL-NH(2) to compare and contrast Ca(2+) changes and amylase secretion triggered by CCK receptor and PAR2 stimulation. We found that secretion stimulated by both agonists is dependent on a rise in cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) and that this rise in [Ca(2+)](i) reflects both the release of Ca(2+) from intracellular stores and accelerated Ca(2+) influx. Both agonists, at low concentrations, elicit oscillatory [Ca(2+)](i) changes, and both trigger a peak plateau [Ca(2+)](i) change at high concentrations. Although the two agonists elicit similar rates of amylase secretion, the rise in [Ca(2+)](i) elicited by caerulein is greater than that elicited by SLIGRL-NH(2). In Ca(2+)-free medium, the rise in [Ca(2+)](i) elicited by SLIGRL-NH(2) is prevented by the prior addition of a supramaximally stimulating concentration of caerulein, but the reverse is not true; the rise elicited by caerulein is neither prevented nor reduced by prior addition of SLIGRL-NH(2). Both the oscillatory and the peak plateau [Ca(2+)](i) changes that follow PAR2 stimulation are prevented by the phospholipase C (PLC) inhibitor U73122, but U73122 prevents only the oscillatory [Ca(2+)](i) changes triggered by caerulein. We conclude that 1) both PAR2 and CCK stimulation trigger amylase secretion that is dependent on a rise in [Ca(2+)](i) and that [Ca(2+)](i) rise reflects release of calcium from intracellular stores as well as accelerated influx of extracellular calcium; 2) PLC mediates both the oscillatory and the peak plateau rise in [Ca(2+)](i) elicited by PAR2 but only the oscillatory rise in [Ca(2+)](i) elicited by CCK stimulation; and 3) the rate of amylase secretion elicited by agonists acting via different types of receptors may not correlate with the magnitude of the [Ca(2+)](i) rise triggered by those different types of secretagogue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976386     DOI: 10.1152/ajpgi.00342.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  9 in total

Review 1.  Pancreatic protease-activated receptors: friend and foe.

Authors:  Fred Gorelick
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

2.  Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis.

Authors:  E S Michael; A Kuliopulos; L Covic; M L Steer; G Perides
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

Review 3.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

4.  Biliary acute pancreatitis in mice is mediated by the G-protein-coupled cell surface bile acid receptor Gpbar1.

Authors:  George Perides; Johanna M Laukkarinen; Galya Vassileva; Michael L Steer
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

5.  Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis.

Authors:  Vandanajay Bhatia; Cristiana Rastellini; Song Han; Judith F Aronson; George H Greeley; Miriam Falzon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-17       Impact factor: 4.052

6.  A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate.

Authors:  Johanna M Laukkarinen; Gijs J D Van Acker; Eric R Weiss; Michael L Steer; George Perides
Journal:  Gut       Date:  2007-06-25       Impact factor: 23.059

7.  Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis.

Authors:  Johanna M Laukkarinen; Eric R Weiss; Gijs J D van Acker; Michael L Steer; George Perides
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

8.  Necroptosis Is an Important Severity Determinant and Potential Therapeutic Target in Experimental Severe Pancreatitis.

Authors:  Johanna Louhimo; Michael L Steer; George Perides
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-07

Review 9.  Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.

Authors:  Savio George Barreto; Aida Habtezion; Anna Gukovskaya; Aurelia Lugea; Christie Jeon; Dhiraj Yadav; Peter Hegyi; Viktória Venglovecz; Robert Sutton; Stephen J Pandol
Journal:  Gut       Date:  2020-09-24       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.